Tissue and organ transplantation involves replacing a damaged or missing organ with a healthy organ from another person. This integrated approach helps patients suffering from organ failure, supporting conditions like heart, kidney and liver diseases. The growing pool of voluntary organ donors and initiatives by health organizations to promote organ donation have significantly boosted transplant procedures.

The global Tissue And Organ Transplantation Market is estimated to be valued at Us$ 18.05 Bn in 2023 and is expected to exhibit a CAGR Of 7.9% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

High Growth owing to Rising Number of Organ Donations
The rising number of organ donations has been a key driver bolstering the tissue and organ transplantation market growth over the past decade. A steady uptick in voluntary organ donation registration along with initiatives by NGOs and governments to raise awareness about organ donation post death have expanded the organ donor pool globally. According to the Global Observatory on Donation and Transplantation, over 135,000 solid organ transplants were performed globally in 2019, reflecting a 5.4% increase in volume from 2010. The growing acceptance of deceased organ donation in countries with traditionally low donation rates such as China, Latin America and the Middle East is anticipated.

SWOT Analysis

- The tissue and organ transplantation market helps save lives by performing organ transplants and tissue replacement procedures. Successful transplantation improves patients' quality of life.
- New technologies like 3D bioprinting and tissue engineering help address the gap between organ supply and demand by developing alternatives to whole organ transplantations.
- There is a severe shortage of organ donors globally which leads to long waiting periods for patients requiring transplantations. Many patients die while waiting for donor organs.
- Transplant rejection remains a major challenge. Patients require strong immuno-suppressants post transplantation which can cause side effects.


- Growth in aging population and incidence of chronic diseases like cardiovascular diseases drives demand for transplantation procedures.
- Development of innovative techniques to preserve donor organs and reduce cold ischemia time helps expand the donor pool and optimize organ utilization.
- Stringent regulatory environment for new product approvals increases costs and timelines for market launch of new technologies.
- Ethical issues around source of organs for transplantation and commercial trading of human organs restrict market growth.

Key Takeaways

The global Tissue And Organ Transplantation Market Demand  is expected to witness high growth over the forecast period of 2023 to 2030 supported by increasing aging population, rise in chronic illnesses and technological advancements.

Regional analysis:

North America currently dominates the market supported by presence of major market players, rising healthcare spending and favorable reimbursement policies. However, Asia Pacific is expected to grow at the fastest pace on back of large patient population, improving healthcare infrastructure and increasing medical tourism.

Key players:

Key players operating in the tissue and organ transplantation market are Probi AB, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc, BioGaia AB, Probiotics International Limited (Protexin), UAS Laboratories LLC. These players are focusing on new product launches, partnerships and expanding to emerging markets to strengthen their position.


Get more insights on this topic :


Check more trending articles on this topic: 


Comments (0)
No login
Login or register to post your comment